Association of TCF7L2 polymorphism with diabetes mellitus, metabolic syndrome, and markers of beta cell function and insulin resistance in a population-based sample of Emirati subjects

Diabetes Research and Clinical Practice

Volumn 80, Issue 3, 2008, Pages 392-398

  Saadi, Hussein ^a   Nagelkerke, Nicolaas ^a   Carruthers, S George ^a   Benedict, Sheela ^a   Abdulkhalek, Samar ^b   Reed, Richard ^c   Lukic, Miodrag ^a   Nicholls, M Gary ^d  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b Health Authority Abu Dhabi   (United Arab Emirates)

^c FLINDERS UNIVERSITY   (Australia)

^d UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Diabetes mellitus; Metabolic syndrome; Pre diabetes; Single nucleotide polymorphisms; Transcription factor 7 like 2 gene; United Arab Emirates

Indexed keywords

TRANSCRIPTION FACTOR 7 LIKE 2;

ADULT; AGE DISTRIBUTION; AGED; ARAB; ARTICLE; BODY MASS; CELL FUNCTION; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PANCREAS ISLET BETA CELL; POPULATION RESEARCH; PREVALENCE; RISK ASSESSMENT; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED ARAB EMIRATES; WAIST CIRCUMFERENCE;

ADULT; AGED; ARABS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; TCF TRANSCRIPTION FACTORS; UNITED ARAB EMIRATES; VARIATION (GENETICS);

EID: 43049165958     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.01.008     Document Type: Article

References (41)

1. Malik M., Bakir A., Abi Saab B., and King H. Glucose intolerance and associated factors in the multi-ethnic population of the United Arab Emirates: results of a national survey. Diabetes Res. Clin. Pract. 69 (2005) 188-195
2. Saadi H., Carruthers S.G., Nagelkerke N., Al-Maskari F., Afandi B., Reed R., et al. Prevalence of diabetes mellitus and its complications in a population-based sample in Al Ain, United Arab Emirates. Diabetes Res. Clin. Pract. May (2007) (Epub ahead of print)
3. International Diabetes Federation, Diabetes Atlas, third ed., 2006.
4. Al-Nozha M.M., Al-Maatouq M.A., Al-Mazrou Y.Y., Al-Harthi S.S., Arafah M.R., Khalil M.Z., et al. Diabetes mellitus in Saudi Arabia. Saudi Med. J. 25 (2004) 1603-1610
5. el Mugamer I.T., Ali Zayat A.S., Hossain M.M., and Pugh R.N. Diabetes, obesity and hypertension in urban and rural people of bedouin origin in the United Arab Emirates. J. Trop. Med. Hyg. 98 (1995) 407-415
6. Carter A., Saadi H., Reed R.L., and Dunn E.V. Obesity, lifestyle and reproductive health in a representative sample of women citizens of Al Ain, United Arab Emirates. J. Health Popul. Nutr. 22 (2004) 75-83
7. Grant S.F., Thorleifsson G., Reynisdottir I., Benediktsson R., Manolescu A., Sainz J., et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat. Genet. 38 (2006) 320-323
8. Sladek R., Rocheleau G., Rung J., Dina C., Shen L., Serre D., et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445 (2007) 881-885
9. Altshuler D., Hirschhorn J.N., Klannemark M., Lindgren C.M., Vohl M.C., Nemesh J., et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat. Genet. 26 (2000) 76-80
10. Gloyn A.L., Weedon M.N., Owen K.R., Turner M.J., Knight B.A., Hitman G., et al. Large-scale association studies of variants in genes encoding the pancreatic beta-cell K-ATP channel subunits Kir6.2 (KCNJ11) and SUR1 ABCC8) confirm that the KCNJ11 E23K variant is associated with Type 2 diabetes. Diabetes 52 (2003) 568-572
11. Helgason A., Palsson S., Thorleifsson G., Grant S.F., Emilsson V., Gunnarsdottir S., et al. Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nat. Genet. 39 (2007) 218-225
12. Scott L.J., Bonnycastle L.L., Willer C.J., Sprau A.G., Jackson A.U., Narisu N., et al. Association of transcription factor 7-like 2 (TCF7L2) variants with type 2 diabetes in a Finnish sample. Diabetes 55 (2006) 2649-2653
13. Saxena R., Gianniny L., Burtt N.P., Lyssenko V., Giuducci C., Sjogren M., et al. Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals. Diabetes 55 (2006) 2890-2895
14. Florez J.C., Jablonski K.A., Bayley N., Pollin T.I., de Bakker P.I., Shuldiner A.R., et al. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N. Engl. J. Med. 355 (2006) 241-250
15. Dahlgren A., Zethelius B., Jensevik K., Syvanen A.C., and Berne C. Variants of the TCF7L2 gene are associated with beta cell dysfunction and confer an increased risk of type 2 diabetes mellitus in the ULSAM cohort of Swedish elderly men. Diabetologia 50 (2007) 1852-1857
16. Damcott C.M., Pollin T.I., Reinhart L.J., Ott S.H., Shen H., Silver K.D., et al. Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish: replication and evidence for a role in both insulin secretion and insulin resistance. Diabetes 55 (2006) 2654-2659
17. Cauchi S., El Achhab Y., Choquet H., Dina C., Krempler F., Weitgasser R., et al. TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. J. Mol. Med. 85 (2007) 777-782
18. Chandak G.R., Janipalli C.S., Bhaskar S., Kulkami S.R., Mohankrishna P., Hattersley A.T., et al. Common variants in the TCF7L2 gene are strongly associated with type 2 diabetes mellitus in the Indian population. Diabetologia 50 (2007) 63-67
19. Horikoshi M., Hara K., Ito C., Nagai R., Froguel P., and Kadowaki T. A genetic variation of the transcription factor 7-like 2 gene is associated with risk of type 2 diabetes in the Japanese population. Diabetologia 50 (2007) 747-751
20. Guo T., Hanson R.L., Traurig M., Muller Y.L., Ma L., Mack J., et al. TCF7L2 is not a major susceptibility gene for type 2 diabetes in Pima Indians: an analysis of 3501 individuals. Diabetes October (2007) (Epub ahead of print)
21. Mori H., Ikegami H., Kawaguchi Y., Seino S., Yokoi N., Takeda J., et al. Brief genetics report the Pro12 → Ala substitution in PPAR γ is associated with resistance to development of diabetes in the general population possible involvement in impairment of insulin secretion in individuals with type 2 diabetes. Diabetes 50 (2001) 891-894
22. Frederiksen L., Broadbaek K., Fenger M., Jorgensen T., Borch-Johnsen K., Madsbad S., et al. Comment: studies of the Pro12Ala polymorphism of the PPAR gene in the Danish MONICA cohort: homozygosity of the Ala allele confers a decreased risk of the insulin resistance syndrome. J. Clin. Endocrinol. Metab. 87 (2002) 3989-3992
23. Badii R., Bener A., Zirie M., Al-Rikabi A., Simsek M., Al-Hamaq A.O., et al. Lack of association between the Pro(12)Ala polymorphism of the PPAR-gamma2 gene and type 2 diabetes mellitus in the Qatari consanguineous population. Acta Diabetol. September (2007) (Epub ahead of print)
24. Zouari Bouassida K., Chouchane L., Jellouli K., Cherif S., Haddad S., Gabbouj S., et al. The peroxisome proliferator activated receptorgamma2 (PPARgamma2) Pro12Ala variant: lack of association with type 2 diabetes in obese and non-obese Tunisian patients. Diabetes Metab. 31 (2005) 119-123
25. World Health Organization, Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications, Report of a WHO Consultation, WHO/NCD/NCS/99.2, Geneva, 1999.
26. Alberti K.G., Zimmet P., and Shaw J. Metabolic syndrome-a new world-wide definition: a consensus statement from the International Diabetes Federation. Lancet 366 (2005) 1059-1062
27. O.B. Ahmad, C. Boschi-Pinto, A.D. Lopez, C.J.L. Murray, R. Lozano, M. Inoue, Age standardization of rates: a new WHO standard, World Health Organization (GPE Discussion Paper Series: No. 31), Geneva, 2000.
28. Wallace T.M., Levy J.C., and Matthews D.R. Use and abuse of HOMA modeling. Diabetes Care 27 (2004) 1487-1495
29. Stumvoll M., Mitrakou A., Pimenta W., Jenssen T., Yki-Jarvinen H., Van Haeften T., et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23 (2000) 295-301
30. Shi Y.Y., and He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 15 (2005) 97-98
31. Chang Y.C., Chang T.J., Jiang Y.D., Kuo S.S., Lee K.C., Lee K.C., et al. Association study of the genetic polymorphisms of the transcription factor 7-like 2 (TCF7L2) gene and type 2 diabetes in the Chinese population. Diabetes 56 (2007) 2631-2637
32. Wang J., Kuusisto J., Vänttinen M., Kuulasmaa T., Lindstrom J., Tuomilehto J., et al. Variants of transcription factor 7-like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the Finnish Diabetes Prevention Study and are associated with impaired glucose regulation and impaired insulin secretion. Diabetologia 50 (2007) 1192-1200
33. De Silva N.M., Steele A., Shields B., Knight B., Parnell K., Weedon M.N., et al. The transcription factor 7-like 2 (TCF7L2) gene is associated with Type 2 diabetes in UK community-based cases, but the risk allele frequency is reduced compared with UK cases selected for genetic studies. Diabet. Med. 24 (2007) 1067-1072
34. Melzer D., Murray A., Hurst A.J., Weedon M.N., Bandinelli S., Corsi A.M., et al. Effects of the diabetes linked TCF7L2 polymorphism in a representative older population. BMC Med. 4 (2006) 34
35. Zeggini E., and McCarthy M.I. TCF7L2: the biggest story in diabetes genetics since HLA?. Diabetologia 50 (2007) 1-4
36. Lyssenko V., Lupi R., Marchetti P., Del Guerra S., Orho-Melander M., Almgren P., et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J. Clin. Invest. 117 (2007) 2155-2163
37. Al-Lawati J.A., Mohammed A.J., Al-Hinai H.Q., and Jousilahti P. Prevalence of the metabolic syndrome among Omani adults. Diabetes Care 26 (2003) 1781-1785
38. Abdul-Rahim H.F., Husseini A., Bjertness E., Giacaman R., Gordon N.H., and Jervell J. The metabolic syndrome in the West Bank population: an urban-rural comparison. Diabetes Care 24 (2001) 275-279
39. Jaber L.A., Brown M.B., Hammad A., Zhu Q., and Herman W.H. The prevalence of the metabolic syndrome among Arab Americans. Diabetes Care 27 (2004) 234-238
40. Ford E.S., Giles W.H., and Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287 (2002) 356-359
41. Weedon M.N. The importance of TCF7L2. Diabet. Med. 24 (2007) 1062-1066